Novavax Inc (NVAX)

[mick]

$NVAX RIGHT IN DA THICK OF CORONAVIRUS VACCINE !!!!!

RE;
phase 3 testing

AZN
MRNA
SINOVAC


Chinese drugmaker Sinovac reported in June that its COVID-19 vaccine candidate CoronaVac produced neutralizing antibodies in over 90% of patients in a phase 1/2 clinical study.

Results from a phase 1 study of AZD1222, the COVID-19 vaccine candidate being developed by AstraZeneca and the University of Oxford, are expected to be published on July 20 in The Lancet medical journal.